8-K 1 0001.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report: August 23, 2000 ALLIED HEALTHCARE PRODUCTS, INC. (Exact Name of Registrant as Specified in Charter) Delaware 0-19266 23-1370721 (State or Other (Commission (IRS Employer Jurisdiction of File Number) Identification No.) Incorporation) 1720 Sublette Avenue St. Louis, MO 63110 (Address of Principal Executive Offices) (Zip Code) (314) 771-2400 (Registrant's telephone number, including area code) page 1 of 5 ITEM 5. OTHER EVENTS. On August 23, 2000, the Registrant issued a news release that is has named Gregory C. Kowert, vice president-finance, chief financial officer and secretary. Mr. Kowert replaces Thomas A. Jenuleson, CFO since March 1999, who has resigned to pursue other interests. The news release is attached as Exhibit 1 hereto, is incorporated herein by reference and made a part hereof. page 2 of 5 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALLIED HEALTHCARE PRODUCTS, INC. Date: August 23, 2000 By: /s/ Earl R. Refsland ----------------------------- Name: Earl R. Refsland Title: President and Chief Executive Officer Page 3 of 5 EXHIBIT INDEX Exhibit No. Description Page No. ----------- ----------- -------- 1. News Release dated August 23, 2000 5 page 4 of 5